Q1Medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource

August 2014 Summary of the Most Recent Updates for the Medicare Part D Plan Formularies (Drug Lists)

Category: Monthly Formulary Changes
Published: Aug, 16 2014 02:08:24
< Previous
Next >
The most recent (August 2014) Medicare Part D plan formulary data (or drug lists) updates include the addition of 87 new National Drug Codes (NDC) to the Medicare Part D program.  These NDCs represent 58 different drugs, many with multiple strengths or delivery forms.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary is a follows:

Reason for NDC Addition Occurrences
New Delivery Form 1
New Drug 23
New Drug and Strength 33
New Manufacturer 10
New Manufacturer and Delivery Form 1
New Manufacturer and Strength 9
 New Packaging
  3
New Strength 7
Total New NDCs 87



The following 87 manufacturer / drug / strength / packaging combinations (NDCs) were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
66993088445 Adapalene 0.3% gel New Manufacturer and Strength
00093517244 Alendronate Sodium 35mg, 4 BLISTER PACK in 1 BOX / 1 TABLET per BLISTER PACK New Packaging
43598032130 Amlodipine-Atorvastatin 10-10 mg [Caduet] New Drug and Strength
00378451893 Amlodipine-Atorvastatin 10-20 mg [Caduet] New Drug and Strength
00378451993 Amlodipine-Atorvastatin 10-40 mg [Caduet] New Drug and Strength
43598031330 Amlodipine-Atorvastatin 10-80 mg [Caduet] New Drug and Strength
43598032330 Amlodipine-Atorvastatin 2.5-10 mg [Caduet] New Drug and Strength
43598032030 Amlodipine-Atorvastatin 2.5-20 mg [Caduet] New Drug and Strength
43598031730 Amlodipine-Atorvastatin 2.5-40 mg [Caduet] New Drug and Strength
43598032230 Amlodipine-Atorvastatin 5-10 mg [Caduet] New Drug and Strength
43598031930 Amlodipine-Atorvastatin 5-20 mg [Caduet] New Drug and Strength
43598031630 Amlodipine-Atorvastatin 5-40 mg [Caduet] New Drug and Strength
43598031430 Amlodipine-Atorvastatin 5-80 mg [Caduet] New Drug and Strength
63402020230 APTIOM 200 MG TABLET New Drug and Strength
63402020430 APTIOM 400 MG TABLET New Drug and Strength
63402020660 APTIOM 600 MG TABLET New Drug and Strength
63402020830 APTIOM 800 MG TABLET New Drug and Strength
65162069388 ATOVAQUONE 750 MG/5 ML SUSP [Mepron] New Drug
59730650301 BIVIGAM LIQUID 10% VIAL New Drug
00781716595 Calcipotriene-Betamethasone Dipropionate Ointment [Taclonex] New Drug
43975022010 CARBIDOPA 25 MG TABLET [Lodosyn] New Drug
10122032510 CARDENE-NACL 40 MG/200 ML IV New Strength
00069020101 Cladribine 10 mg/10 ml vial New Drug
55292081155 COSMEGEN 0.5 MG VIAL New Drug
00006057362 CRIXIVAN 400mg, 180 CAPSULE BOTTLE New Packaging
55292010201 DESOXYN 5 MG TABLET New Manufacturer
67457020725 Dexrazoxane 500 mg vial New Drug
66490065020 DIASTAT 2.5 MG PEDI SYSTEM New Drug and Strength
00187065920 DIASTAT ACUDIAL 12.5-15-20 MG New Drug and Strength
00187065820 DIASTAT ACUDIAL 5-7.5-10 MG KT New Drug and Strength
49281022558 DIPHTHERIA-TETANUS TOXOIDS-PED New Drug
00093553756 Eszopiclone 1 mg tablet [Lunesta] New Drug and Strength
68180032301 Eszopiclone 2 mg tablet [Lunesta] New Drug and Strength
68180032401 Eszopiclone 3 mg tablet [Lunesta] New Drug and Strength
40076005100 EXTINA 2% FOAM New Manufacturer
44001032107 FACTIVE 320 MG TABLET New Drug
00006422930 GRASTEK 2;800 BAU SL TABLET New Drug
43068022001 HETLIOZ 20 MG CAPSULE New Drug
62756021840 IBANDRONATE 3 MG/3 ML VIAL New Manufacturer and Strength
00074302313 K-TAB ER 20 MEQ TABLET New Strength
13551010105 KARBINAL ER SUS 4MG/5ML New Drug
24987007501 KAYEXALATE POWDER New Drug
16714040801 LARIN 21 1-20 tablet New Drug
16714040604 LARIN FE 1-20 TABLET New Drug and Strength
16714040504 LARIN FE 1.5-30 TABLET New Drug and Strength
68308022101 Lorcet 5-325 mg tablet New Manufacturer and Strength
68308022301 Lorcet hd 10-325 mg tablet New Drug
50474093201 Lortab 10-325 mg tablet New Strength
50474093001 Lortab 5-325 mg tablet New Strength
50474093101 Lortab 7.5-325 mg tablet New Strength
63323012250 Methotrexate 1 gm vial New Strength
00703367101 Methotrexate 25 mg/ml vial New Manufacturer
00378557393 Modafinil 100 mg tablet New Packaging
00115147154 MOMETASONE FUROATE 0.1% SOLN New Manufacturer and Delivery Form
00409189011 Morphine 2 mg/ml isecure syr New Manufacturer and Strength
00409189111 Morphine 4 mg/ml isecure syr New Manufacturer and Strength
00093738756 MOXIFLOXACIN HCL 400 MG TABLET New Drug
00259110260 NAFTIN 2% CREAM New Delivery Form
60505405803 Nevirapine er 400 mg tablet New Manufacturer and Strength
57664013560 Nimodipine 30 mg capsule New Manufacturer
52544025928 NORINYL 1+35-28 TABLET 6 BLISTER PACK per CARTON / 1 KIT per BLISTER PACK New Drug
66302030001 ORENITRAM ER 0.125 MG TABLET New Drug and Strength
66302030201 ORENITRAM ER 0.25 MG TABLET New Drug and Strength
66302031001 ORENITRAM ER 1 MG TABLET New Drug and Strength
66302032501 ORENITRAM ER 2.5 MG TABLET New Drug and Strength
59572063027 OTEZLA 10-20-30MG New Manufacturer and Strength
59572063106 OTEZLA 30 MG TABLET New Manufacturer and Strength
55292060101 PEGANONE 250 MG TABLET New Manufacturer
00085130401 PEGINTRON 120 MCG KIT per CARTON New Drug and Strength
00085127901 PEGINTRON 150 MCG KIT per CARTON New Drug and Strength
00085129101 PEGINTRON 80 MCG KIT per CARTON New Drug and Strength
00006542030 RAGWITEK SUBLINGUAL TABLET New Drug
00093729001 Raloxifene HCl 60 mg tablet [Evista] New Drug
68382042306 RANITIDINE HCL 150 MG/6 ML VL New Manufacturer and Strength
68180028501 RIFABUTIN 150 MG CAPSULE New Drug
00378290177 Telmisartan-HCTZ 40-12.5 mg tablet New Drug and Strength
00378290277 Telmisartan-HCTZ 80-12.5 mg tablet New Drug and Strength
00378290377 Telmisartan-HCTZ 80-25 mg tablet New Drug and Strength
55292030301 TRANXENE T-TAB 15 MG New Manufacturer
55292030101 TRANXENE T-TAB 3.75 MG New Manufacturer
55292030201 TRANXENE T-TAB 7.5 MG New Manufacturer
00187014210 VASOTEC 10 MG TABLET New Manufacturer
00187014190 VASOTEC 5 MG TABLET New Manufacturer
00093304301 VERAPAMIL ER 120 MG TABLET New Strength
63323027810 VINBLASTINE 1 MG/ML VIAL New Drug
23635011501 XARTEMIS XR 7.5-325 MG TABLET New Drug
00378334053 Xulane Patch New Drug




You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, October 2012, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
May 2023, August 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com



© Q1Group LLC 2005 - 2023  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.